CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($) $ in Thousands	Common Stock	Preferred Stock Series A Preferred Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Beginning balance at Dec. 31, 2021	$ 59		$ 203,990	$ (183,243)		$ 20,806
Beginning balance ,shares at Dec. 31, 2021	58,810,550
Common stock and warrants issued, net of issuance costs	$ 8		22,972			22,980
Common stock and warrants issued, net of issuance costs (in shares)	7,824,727
Stock-based compensation			1,334			1,334
Common stock issued for consulting services			17			17
Common stock issued for consulting services (in shares)	6,037
Net loss				(13,448)		(13,448)
Ending balance at Mar. 31, 2022	$ 67		228,313	(196,691)		31,689
Ending balance ,shares at Mar. 31, 2022	66,641,314
Beginning balance at Dec. 31, 2021	$ 59		203,990	(183,243)		$ 20,806
Beginning balance ,shares at Dec. 31, 2021	58,810,550
Common stock and warrants issued, net of issuance costs (in shares)						7,824,727
Net loss						$ (29,513)
Ending balance at Sep. 30, 2022	$ 68		229,470	(212,756)		16,782
Ending balance ,shares at Sep. 30, 2022	67,641,314
Beginning balance at Mar. 31, 2022	$ 67		228,313	(196,691)		31,689
Beginning balance ,shares at Mar. 31, 2022	66,641,314
Stock-based compensation			987			987
Additional issuance costs in connection with Private Placement			(342)			(342)
Net loss				(6,982)		(6,982)
Ending balance at Jun. 30, 2022	$ 67		228,958	(203,673)		25,352
Ending balance ,shares at Jun. 30, 2022	66,641,314
Stock-based compensation			541			541
Additional issuance costs in connection with Private Placement			(28)			(28)
Restricted stock awards granted (in Shares)	1,000,000
Restricted stock awards granted	$ 1		(1)
Net loss				(9,083)		(9,083)
Ending balance at Sep. 30, 2022	$ 68		229,470	(212,756)		16,782
Ending balance ,shares at Sep. 30, 2022	67,641,314
Beginning balance at Dec. 31, 2022	$ 67		230,339	(222,997)		7,409
Beginning balance ,shares at Dec. 31, 2022	66,442,989
Common stock and warrants issued, net of issuance costs	$ 3		2,542			2,545
Common stock and warrants issued, net of issuance costs (in shares)	3,866,666
Change in fair value of convertible note attributed to credit risk					$ 106	106
Stock-based compensation			695			695
Net loss				(11,039)		(11,039)
Ending balance at Mar. 31, 2023	$ 70		233,576	(234,036)	106	(284)
Ending balance ,shares at Mar. 31, 2023	70,309,655
Beginning balance at Dec. 31, 2022	$ 67		230,339	(222,997)		7,409
Beginning balance ,shares at Dec. 31, 2022	66,442,989
Change in fair value of convertible note attributed to credit risk						(22)
Common stock issued as repayment of principal and interest for convertible note						982
Net loss						(25,818)
Ending balance at Sep. 30, 2023	$ 84	$ 3	242,533	(248,815)	(22)	(6,217)
Ending balance ,shares at Sep. 30, 2023	83,919,554	3,000,000
Beginning balance at Mar. 31, 2023	$ 70		233,576	(234,036)	106	(284)
Beginning balance ,shares at Mar. 31, 2023	70,309,655
Common stock and warrants issued, net of issuance costs	$ 10		5,567			5,577
Common stock and warrants issued, net of issuance costs (in shares)	9,670,002
Change in fair value of convertible note attributed to credit risk					(128)	(128)
Stock-based compensation			544			544
Common stock issued as repayment of principal and interest for convertible note			200			200
Common stock issued as repayment of principal and interest for convertible note (in shares)	408,673
Net loss				(8,717)		(8,717)
Ending balance at Jun. 30, 2023	$ 80		239,887	(242,753)	(22)	(2,808)
Ending balance ,shares at Jun. 30, 2023	80,388,330
Stock-based compensation			351			351
Preferred stock and warrants issued, net of issuance costs		$ 3	1,168			1,171
Preferred stock and warrants issued, net of issuance costs (in shares)		3,000,000
Common stock issued to settle GEM settlement liability	$ 1		249			250
Common stock issued to settle GEM settlement liability (in shares)	675,676
Common stock issued as repayment of principal and interest for convertible note	$ 3		779			782
Common stock issued as repayment of principal and interest for convertible note (in shares)	2,855,548
Adjustments to Additional Paid in Capital, Deferred Offering Cost Settlement			99			99
Net loss				(6,062)		(6,062)
Ending balance at Sep. 30, 2023	$ 84	$ 3	$ 242,533	$ (248,815)	$ (22)	$ (6,217)
Ending balance ,shares at Sep. 30, 2023	83,919,554	3,000,000